TL;DR
Get business pricing on tech for your team
- Business-only prices and quantity discounts
- Tax-exempt purchasing
- Multiple users, one account, clear invoices
Medicare has introduced a new payment model, ACCESS, that rewards health outcomes and enables AI-driven care. The program, launching July 5, marks a significant shift in healthcare reimbursement, but the tech industry largely remains uninformed.
Medicare’s new program, ACCESS, officially launches on July 5, 2024, creating a payment framework that rewards health outcomes rather than traditional activity-based reimbursement, enabling AI-driven healthcare solutions at a federal scale. This development is significant because it marks the first time Medicare’s reimbursement structure directly supports AI monitoring and intervention, with most of the tech industry still largely unaware of its implications.
The ACCESS program, managed by the Centers for Medicare & Medicaid Services (CMS), is a 10-year initiative designed to test a new payment model that incentivizes measurable health outcomes for chronic conditions such as diabetes, hypertension, and mental health issues. Unlike traditional Medicare, which pays based on time spent with clinicians, ACCESS offers predictable payments for managing conditions, with full rewards contingent on achieving specific health goals. This model creates a pathway for AI tools—like virtual health assistants, remote monitoring devices, and behavioral coaching platforms—to be reimbursed for their role in patient care.
Neil Batlivala, founder of healthcare company Pair Team, highlighted that this is a ‘payment model transformation’ that allows AI to be integrated into care workflows in ways previously impossible under conventional reimbursement rules. Pair Team, which manages a large community health workforce and employs AI agents such as Flora, has been preparing for this shift for years, focusing on underserved populations with complex needs. The program includes diverse participants, from AI startups to connected device companies, aiming to demonstrate scalable, outcome-based care models. Despite the promise, concerns remain about data security, given the sensitive nature of health information processed through federal systems, and about whether reimbursement rates will sustain large-scale AI deployment, as CMS has historically paid less than some organizations anticipated.
Why It Matters
This development is significant because it signals a fundamental shift in healthcare reimbursement, moving toward outcome-based models that explicitly incorporate AI and digital health tools. If successful, it could accelerate AI adoption in healthcare by providing a clear financial incentive, especially for addressing complex, underserved populations. It also challenges existing regulatory and industry norms, potentially reshaping how healthcare services are delivered and paid for at a national level.
As an affiliate, we earn on qualifying purchases.
Background
For years, CMS has experimented with value-based care models, but most have not explicitly included AI as a reimbursable component. The ACCESS program, designed by former startup founders within CMS, aims to test whether outcome-based payments can foster innovation. The program builds on prior initiatives but emphasizes direct-to-consumer enrollment, competition, and outcome metrics. Pair Team’s deployment of Flora, a voice AI agent, exemplifies how AI can handle patient engagement, coordination, and monitoring—functions traditionally performed by human teams. The program’s launch follows years of incremental progress in digital health, but its scale and federal backing make it a potentially transformative milestone.
“The government is creating swim lanes for AI innovation in traditionally regulated industries. The best solution wins, which, in regulated industries like healthcare — that’s not been the case.”
— Neil Batlivala
“The design of ACCESS reflects a deliberate push for competition and outcome-based reimbursement, encouraging innovation in digital health.”
— Abe Sutton
remote patient monitoring devices
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It remains unclear how widely the program will be adopted beyond the initial cohort, whether reimbursement rates will be sufficient for large-scale AI deployment, and how data security concerns will be addressed at a federal level. Additionally, the long-term impact on healthcare costs and outcomes is still to be evaluated as the program unfolds.
AI-powered behavioral health coaching
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
The program officially launches on July 5, 2024. Participants will begin implementing AI-driven care models, with ongoing monitoring and evaluation by CMS. Results from the initial cohort will inform potential expansion and policy adjustments. Stakeholders will watch for data security issues, cost-effectiveness, and patient outcomes over the coming months.
outcome-based healthcare monitoring tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is the ACCESS program?
ACCESS is a 10-year CMS initiative that tests a new payment model rewarding health outcomes for chronic disease management, including AI-enabled care, starting July 5, 2024.
How does this change Medicare reimbursement?
It shifts from activity-based payments to outcome-based payments, allowing AI tools to be reimbursed for monitoring, coordination, and intervention efforts that improve patient health.
Why has most of the tech industry not heard about this?
The program’s design and rollout are recent, and many tech companies are unaware of the scale and potential impact, partly due to limited industry communication and focus on traditional healthcare channels.
What are the risks associated with this program?
Data security concerns, especially given sensitive health information processed through federal systems, and questions about reimbursement sufficiency for large-scale AI deployment remain unresolved.
What happens next?
The program begins on July 5, with participating organizations deploying AI solutions, followed by evaluation of outcomes and potential expansion based on initial results and policy adjustments.
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
